Cytokine production in bipolar affective disorder patients under lithium treatment

Journal of Affective Disorders

Volumn 82, Issue 2, 2004, Pages 309-313

  Boufidou, Fotini ^a   Nikolaou, Chryssoula ^a   Alevizos, Basil ^a   Liappas, Ioannis A ^a   Christodoulou, George N ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Bipolar affective disorder; Cytokine production; ELISPOT; Lithium treatment; Psychomeuroimmunology

Indexed keywords

CARBAMAZEPINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; LITHIUM; VALPROIC ACID;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; LONG TERM CARE; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SECRETORY CELL;

ADULT; ANTICONVULSANTS; ANTIMANIC AGENTS; BIPOLAR DISORDER; CARBAMAZEPINE; CYTOKINES; DOWN-REGULATION; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LITHIUM CHLORIDE; LONG-TERM CARE; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; RECURRENCE; VALPROIC ACID;

EID: 5644253241     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2004.01.007     Document Type: Article

References (32)

1. Amsterdam J.D., Maislin G., Rybakowski J.A. Possible antiviral action of lithium carbonate in herpes simplex virus infections. Biol. Psychiatry. 27:1990;447-453
2. Anisman H., Ravindran A.V., Griffiths J., Merali Z. Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features. Mol. Psychiatry. 4:1999;182-188
3. Bubak-Satora M., Skowron-Cendrzak A., Kubera M. The effect of lithium chloride treatment on cell mediated immunity in mice. Folia Biol. 39:1991;21-24
4. Casebolt T.L., Jope R.S. Effects of chronic lithium treatment on protein Kinase C and cyclic AMP-dependent protein phosphorylation. Biol. Psychiatry. 29:1991;233-243
5. Christodoulou G.N. Christodoulou G.N. Psychiatriki. 2000;308-312 Beta Publishers, Athens
6. Czerkinsky C.C., Nilsson L.A., Nygren H., Ouchterlony O., Tarkowski A.A. Solid-phase enzyme-linked immunospot assay (ELISPOT) for enumeration of specific antibody secreting cells. J. Immunol. Methods. 72:1983;489-496
7. Ebstein R.P. Lithium modulation of second messenger signal amplification in man: inhibition phosphatidyl-inositol-specific phospholipase C and adenylate cyclase activity. Psychiatry Res. 24:1988;45-52
8. Favre N., Bordmann G., Rudin W. Comparison of cytokine measurements using ELISA, ELISPOT and semi-quantitative RT-PCR. J. Immunol. Methods. 204:1997;57-66
9. Franci C., Ingles J., Castro R., Vidal J. Further studies on the ELISA-spot technique. Its application to particulate antigens and a potential improvement in sensitivity. J. Immunol. Methods. 88:1986;225-232
10. Jope R.S. Anti-bipolar therapy: mechanism of action of lithium. Mol. Psychiatry. 4:1999;117-128
11. Kook A.I., Mizruchin A., Odnopozov N., Gershon H., Segev Y. Depression and immunity: the biochemical interrelationship between the central nervous system and the immune system. Biol. Psychiatry. 37:1995;817-819
12. Krause G., Zhao P., Martin L., Fritzle M.J., Benediktsson H., Hart D.A. LiCl prolongs survival and alters disease progression in the NZB/W model of systemic lupus erythematosus. Lithium. 3:1992;61-67
13. Kronfol Z., House D. Immune function in mania. Biol. Psychiatry. 24:1988;341-343
14. Kucharz E.J., Sierakowski S.J., Goodwin J.S. Lithium in vitro enhances interleukin-2 production by T cells from patients with systemic lupus erythematosus. Immunopharmacol. Immunotoxicol. 15:1993;515-523
15. Kupka R.W., Hillegers M.H.J., Nolen W.A., Breunis N., Drexhage H.A. Immunological aspects of bipolar disorder. Acta Neuropsychiatr. 12:(3):2000;86-90
16. Leonard B.E., Song C. Stress and the immune system in the etiology of anxiety and depression. Pharmacol. Biochem. Behav. 54:1996;299-303
17. Lieb J. Lithium and immune function. Med. Hypotheses. 23:1987;73-93
18. Maes M., Meltzer H.Y., Bosnans E., Bergmans R., Vandoolaeghe E., Ranjan R., Desnyder R. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J. Affect. Disord. 34:1995;301-309
19. Maes M., Bosmans E., De Jong R., Kenis G., Vandoolaeghe E., Neels H. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine. 9:1997;853-858
20. Maes M., Delange J., Ranjan R., Meltzer H.Y., Bosnans E., Desnyder R., Cooremans W., Scharpe S. Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs. Psychiatry Res. 66:1997;1-11
21. Manjii H.K., Bebchuck J.M., Moore G.J., Glitz D., Hasanat K.A., Chen G. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications. J. Clin. Psychiatry. 2:1999;27-39
22. Mork A., Geisler A. The effects of lithium in vitro and ex vivo on adenylate cyclase in brain are exerted by distinct mechanisms. Neuropharmacology. 28:1989;307-311
23. Muller N., Riedel M., Ackenheil M., Schwarz M. The role of immune function in schizophrenia: an overview. Eur. Arch. Psychiatry Clin. Neurosci. 249:(Suppl. 4):1999;62-68
24. Mustelin T., Coggeshall K.M., Isakow N., Altman A. T cell antigen receptor-mediated activation of phospholipase C requires tyrosine phosphorylation. Science. 247:1990;1584-1587
25. Rapaport M.H. Immune parameters in euthymic bipolar patients and normal volunteers. J. Affect. Disord. 32:1994;149-156
26. Rapaport M.H., Manji H.K. The effects of lithium on ex vivo cytokine production. Biol. Psychiatry. 50:2001;217-224
27. Rapaport M.H., Guylai L., Whybrow P. Immune parameters in rapid cycling bipolar patients before and after lithium treatment. J. Psychiatr. Res. 33:1999;335-340
28. Schwarz M.J., Riedel M., Ackenheil M., Muller N. Decreased levels of soluble intercellular adhesion molecule-1 (sICAM-1) in unmedicated and medicated schizophrenic patients. Biol. Psychiatry. 47:2000;29-33
29. Sluzewska A., Rybakowski J., Bosmans E., Sobieska M., Berghmans R., Maes M., Wiktorowicz K. Indicators of immune activation in major depression. Psychiatry Res. 64:1996;161-167
30. Sluzewska A., Sobieska M., Rybakowski J.K. Changes in acute-phase proteins during lithium potentiation of antidepressants in refractory depression. Neuropsychobiology. 35:1997;123-127
31. Tsai S.-Y., Chen K.-P., Yang Y., Chen C.C., Lee J.C., Singh V.K., Leu S.-J. Activation of indices of cell-mediated immunity in bipolar mania. Biol. Psychiatry. 45:1999;989-994
32. Watson D.G., Lenox R.H. Chronic lithium-induced down-regulation of MARCKS in immortalized Hippocampal cells: potentiation by muscarinic receptor activation. J. Neurochem. 67:1996;767-777